Scarica l'app Stockscreener
14.95
6.03%
0.85
Dopo l'orario di chiusura:
15.07
0.12
+0.80%
Precedente Chiudi:
$14.10
Aprire:
$14.4
Volume 24 ore:
3.19M
Relative Volume:
3.33
Capitalizzazione di mercato:
$1.07B
Reddito:
$133.62M
Utile/perdita netta:
$-177.37M
Rapporto P/E:
-5.173
EPS:
-2.89
Flusso di cassa netto:
$23.50M
1 W Prestazione:
+14.47%
1M Prestazione:
+73.43%
6M Prestazione:
+57.04%
1 anno Prestazione:
-30.53%
Intervallo 1D:
$14.38
$15.37
Intervallo di 1 settimana:
$11.17
$15.37
Portata 52W:
$6.92
$27.24
Xencor Inc Stock (XNCR) Company Profile
Nome
Xencor Inc
Settore
Industria
Telefono
626-305-5900
Indirizzo
465 N. HALSTEAD ST., PASADENA, CA
Confronta XNCR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
XNCR
Xencor Inc
|
14.95 | 886.55M | 133.62M | -177.37M | 23.50M | -2.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Xencor Inc Stock (XNCR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-17 | Ripresa | Barclays | Underweight |
| 2025-09-03 | Downgrade | BofA Securities | Buy → Neutral |
| 2025-04-21 | Iniziato | William Blair | Outperform |
| 2024-12-12 | Iniziato | Wells Fargo | Overweight |
| 2024-12-02 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2024-04-16 | Reiterato | BTIG Research | Buy |
| 2024-02-28 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2023-05-19 | Iniziato | BofA Securities | Buy |
| 2022-12-06 | Iniziato | Cowen | Outperform |
| 2022-10-13 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2022-09-21 | Iniziato | JP Morgan | Overweight |
| 2022-07-06 | Ripresa | Canaccord Genuity | Buy |
| 2022-02-11 | Iniziato | BMO Capital Markets | Outperform |
| 2022-01-21 | Iniziato | SMBC Nikko | Outperform |
| 2021-12-15 | Iniziato | H.C. Wainwright | Buy |
| 2021-10-15 | Ripresa | BTIG Research | Buy |
| 2021-02-24 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-03-04 | Iniziato | Barclays | Underweight |
| 2020-02-25 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-01-30 | Iniziato | RBC Capital Mkts | Outperform |
| 2019-11-20 | Ripresa | Guggenheim | Neutral |
| 2019-08-07 | Downgrade | Guggenheim | Buy → Neutral |
| 2019-08-07 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2019-06-13 | Iniziato | Mizuho | Buy |
| 2019-04-12 | Iniziato | Guggenheim | Buy |
| 2019-03-27 | Iniziato | Berenberg | Buy |
| 2019-03-15 | Iniziato | Raymond James | Outperform |
| 2018-09-10 | Ripresa | BTIG Research | Buy |
| 2018-03-28 | Ripresa | Leerink Partners | Outperform |
| 2017-03-02 | Iniziato | Instinet | Neutral |
| 2017-03-02 | Reiterato | Wedbush | Outperform |
| 2016-10-04 | Iniziato | Piper Jaffray | Overweight |
| 2015-12-22 | Iniziato | Canaccord Genuity | Buy |
| 2015-08-05 | Reiterato | MLV & Co | Buy |
| 2015-02-12 | Reiterato | Oppenheimer | Outperform |
| 2015-01-28 | Reiterato | MLV & Co | Buy |
| 2014-07-11 | Iniziato | Oppenheimer | Outperform |
Mostra tutto
Xencor Inc Borsa (XNCR) Ultime notizie
What to expect from Xencor Inc. in the next 30 daysGlobal Markets & High Conviction Trade Alerts - newser.com
Why analysts remain bullish on Xencor Inc. stockJuly 2025 Price Swings & AI Based Buy and Sell Signals - newser.com
How to manage a losing position in Xencor Inc.July 2025 PreEarnings & Scalable Portfolio Growth Ideas - newser.com
Will Xencor Inc. stock maintain momentum in 2025Dollar Strength & Weekly Top Performers Watchlists - newser.com
What MACD and RSI say about Xencor Inc.2025 Key Lessons & Low Risk High Win Rate Stock Picks - newser.com
Published on: 2025-10-15 11:08:37 - newser.com
Forecasting Xencor Inc. price range with options dataShare Buyback & Weekly Watchlist for Consistent Profits - newser.com
Xencor stock maintains Overweight rating at Cantor Fitzgerald ahead of key webcast - Investing.com Nigeria
Can a trend reversal in Xencor Inc. lead to recoveryPortfolio Return Summary & Capital Protection Trade Alerts - newser.com
Xencor Stock Soars 7.14% to Intraday High Amid Strong Performance - Markets Mojo
Xencor to present initial XmAb819 clinical data for renal cancer at conference - Investing.com Nigeria
Xencor plans early-stage data for cancer drug (XNCR:NASDAQ) - Seeking Alpha
Xencor Announces Presentation of Initial Phase 1 Dose-Escalation Results of XmAb819 in Clear Cell Renal Cell Carcinoma at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics - Business Wire
Is Xencor Inc. (XE9) stock nearing a technical breakoutQuarterly Performance Summary & Fast Entry and Exit Trade Plans - newser.com
Reversal indicators forming on Xencor Inc. stock2025 Market Trends & Real-Time Buy Zone Alerts - newser.com
Xencor Inc. stock prediction for this weekCEO Change & Short-Term Trading Opportunity Alerts - newser.com
Can Xencor Inc. stock continue upward trend2025 Trade Ideas & Low Drawdown Trading Strategies - newser.com
Published on: 2025-10-13 00:04:16 - newser.com
Equities Analysts Issue Forecasts for Xencor FY2025 Earnings - MarketBeat
Xencor, Inc. (NASDAQ:XNCR) Given Average Rating of “Moderate Buy” by Analysts - Defense World
How hedge fund analytics apply to Xencor Inc. stockLayoff News & Verified Momentum Stock Alerts - newser.com
How Xencor Inc. stock performs in rising dollar environmentMarket Risk Analysis & Trade Opportunity Analysis Reports - newser.com
What’s next for Xencor Inc. stock priceJuly 2025 Setups & Safe Swing Trade Setup Alerts - newser.com
Xencor (NASDAQ:XNCR) Raised to Strong-Buy at Cantor Fitzgerald - MarketBeat
What does recent volatility data suggest for Xencor Inc.July 2025 Reactions & Safe Capital Growth Plans - newser.com
Will Xencor Inc. (XE9) stock outperform small cap peersEarnings Overview Summary & Consistent Return Strategy Ideas - newser.com
How to recover losses in Xencor Inc. stockJuly 2025 Fed Impact & Fast Entry High Yield Stock Tips - newser.com
Is Xencor Inc. stock recession proofJuly 2025 Rallies & Verified Entry Point Detection - newser.com
Tracking the Evolving Narrative for Xencor After Mixed Analyst Developments - Yahoo Finance
Cantor Fitzgerald Comments on Xencor FY2025 Earnings - Defense World
Cantor Fitzgerald Forecasts Xencor FY2025 Earnings - MarketBeat
Xencor (NASDAQ:XNCR) Receives Overweight Rating from Cantor Fitzgerald - Defense World
Xencor Inc Azioni (XNCR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Xencor Inc Azioni (XNCR) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| GUSTAFSON KURT A | Director |
Jun 16 '25 |
Sale |
9.22 |
2,993 |
27,595 |
20,183 |
| GORMAN KEVIN CHARLES | Director |
Jun 16 '25 |
Sale |
9.22 |
3,173 |
29,255 |
18,905 |
| Feigal Ellen | Director |
Jun 16 '25 |
Sale |
9.22 |
2,993 |
27,595 |
19,183 |
| RANIERI RICHARD J | Director |
Jun 16 '25 |
Sale |
9.22 |
2,993 |
27,595 |
19,183 |
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):